Not FDA-approved
Bones & muscles
Follistatin-344
Evidence
Limited human data
Class
Myostatin-binding protein
KEY TAKEAWAY
Follistatin-344 is a form of follistatin, a protein that binds and blocks myostatin and activin, which limit muscle growth. Follistatin-344 is not FDA-approved. Human data come mainly from gene-therapy studies in muscular dystrophy, not from injected protein.
Written by the Veylo editorial team · Updated
November 2026
What it is
Myostatin-binding protein
Main uses
Studied in muscle-wasting disease models; sold online for muscle growth
Key fact
Follistatin-344 is not FDA-approved. Human data come mainly from gene-therapy studies in muscular dystrophy, not from injected protein.
Route
Usually injected in animal studies
Evidence strength
Limited human data
Follistatin-344 is a form of follistatin, a protein that binds and blocks myostatin and activin, which limit muscle growth.
By binding myostatin, it removes a brake on muscle growth in animal models.
Follistatin-344 is not FDA-approved. Human data come mainly from gene-therapy studies in muscular dystrophy, not from injected protein.
Studied in muscle-wasting disease models; sold online for muscle growth.
Blocking activin can affect fertility and other tissues. Human safety data on injected products do not exist.
Follistatin-344: see PubMed and ClinicalTrials.gov for published studies and registered trials. No FDA drug label exists for the uses described.
Veylo content is educational and not medical advice. Peptides that are not FDA-approved are not approved for the uses described.